Sign In
Buy HAE
$65.88
-0.490 (-0.738%)
At Close: Jun 03, 2026
Haemonetics Corporation's (HAE) CEO Chris Simon on Q2 2022 Results - Earnings Call Transcript
11:55am, Tuesday, 09'th Nov 2021
Haemonetics Corporation's (HAE) CEO Chris Simon on Q2 2022 Results - Earnings Call Transcript
Haemonetics (HAE) Lags Q2 Earnings and Revenue Estimates
08:25am, Tuesday, 09'th Nov 2021
Haemonetics (HAE) delivered earnings and revenue surprises of -4.76% and -2.44%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Here's Why You Should Retain Haemonetics (HAE) Stock for Now
10:30am, Wednesday, 06'th Oct 2021
Investors are optimistic about Haemonetics (HAE) on strong demand for NexSys PCS system and potential of Hemostasis Management franchise.
Haemonetics' Vascade Vascular Closure Device Includes Same-Day Discharge Label
06:39am, Friday, 01'st Oct 2021
Haemonetics Corp's (NYSE: HAE) Vascade MVP Venous Vascular Closure System becomes the first vascular closure device to receive FDA indication for same-day discharge following atrial fibrillation (A
BOSTON, Sept. 30, 2021 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, ann
Is A Recovery Imminent In Haemonetics Stock After Falling 40% This Year?
08:30am, Thursday, 23'rd Sep 2021
We believe that Haemonetics stock, best known for its blood and plasma supplies and services, is a good buying opportunity at the present time. HAE stock trades near $70 currently and it is, in fact,
Haemonetics To Present At The 19th Annual Morgan Stanley Global Healthcare Conference
08:52am, Wednesday, 25'th Aug 2021
BOSTON, Aug. 25, 2021 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the 19th Annual Morgan Stanley Virtual Global Healthcare Confer
Haemonetics Corporation (HAE) CEO Chris Simon on Q1 2022 Results - Earnings Call Transcript
12:29pm, Wednesday, 11'th Aug 2021
Haemonetics Corporation (HAE) CEO Chris Simon on Q1 2022 Results - Earnings Call Transcript
Haemonetics (HAE) Q1 Earnings and Revenues Top Estimates
08:40am, Wednesday, 11'th Aug 2021
Haemonetics (HAE) delivered earnings and revenue surprises of 6.38% and 1.33%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Haemonetics 1st Quarter Fiscal Year 2022 Earnings Release Available on Investor Relations Website
06:00am, Wednesday, 11'th Aug 2021
BOSTON, Aug. 11, 2021 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its first quarter fiscal 2022, which ended July 3, 2021, are available on its Investor R
Lloyd E. Johnson Joins Haemonetics' Board of Directors; Ellen Zane Announced as New Board Chair
06:45am, Monday, 09'th Aug 2021
BOSTON, Aug. 9, 2021 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, anno
Haemonetics (HAE) Earnings Expected to Grow: Should You Buy?
04:48pm, Wednesday, 04'th Aug 2021
Haemonetics (HAE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Top 5 Trades of the Eaton Vance Worldwide Health Sciences Fund
05:14pm, Monday, 26'th Jul 2021
The Eaton Vance Worldwide Health Sciences Fund (Trades, Portfolio) disclosed its portfolio for the second quarter of the year this week.
Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2022 Results: August 11, 2021
04:10pm, Friday, 09'th Jul 2021
BOSTON, July 9, 2021 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish first quarter fiscal year 2022 financial results at 6:00 am EDT on Wednesday, Au
Here's Why Haemonetics Stock Is Undervalued At $63
10:30am, Thursday, 24'th Jun 2021
We believe that the stock price of Haemonetics, best known for its blood and plasma supplies and services, is undervalued at current levels of $63. HAE stock is down 27% from the levels of around $86
